Please be aware these summaries are produced voluntarily by Biomedical Science students and are their interpretations of the information and findings. This information is reviewed by our Research Analyst Kristina Backlund MMSc. The National Lottery Community Fund and Ionis Pharmaceuticals, Inc have contributed to the funding of the Research Analyst role.
Alex TLC assumes no responsibility or liability for any errors or omissions in the content of these summaries. The information contained in the research summaries is provided on an “as is” basis with no guarantees of completeness, accuracy, usefulness, or timeliness. If you are unsure of any of the details within the summaries, please refer to the actual articles or contact info@alextlc.org
We have developed a database of research summaries that include leukodystrophy articles, clinical trials and pharmaceutical press releases to allow our community to easily read about relevant recent research developments.
Please use the drop down boxes below to narrow your search. You can search for condition specific summaries or to view our monthly research summaries which are sent out via email to our community, please select ‘Monthly summary’.
Adrenomyeloneuropathy (AMN) Spur Therapeutics has made the difficult decision to discontinue clinical development of SBT101 for adrenomyeloneuropathy (AMN). This decision was not based on safety concerns, but rather on the increasingly complex development path for the program. Spur is working with the clinical community to share data from the SBT101 program, which includes the Phase […]
Adrenomyeloneuropathy (AMN) https://pmc.ncbi.nlm.nih.gov/articles/PMC11706703/#jimd12845 Adrenoleukodystrophy (ALD) is a genetic disorder that can affect the spinal cord, leading to mobility and sensory issues. This study followed 79 adult men with ALD over 7 years to understand how spinal cord disease progresses in this condition and is the longest follow up study in this cohort to date. ALD […]
Adrenoleukodystrophy (ALD) and Adrenomyeloneuropathy (AMN) https://pmc.ncbi.nlm.nih.gov/articles/PMC11450743 Adrenoleukodystrophy (ALD) and adrenomyeloneuropathy (AMN) are X-linked genetic disorders with significant lifelong implications. ALD primarily affects men, but women can also develop debilitating symptoms, including progressive neuropathy and myelopathy, though adrenal insufficiency and cerebral demyelination are rare. Early identification of symptoms and establishment of care with a neurologist are […]
Adrenomyeloneuropathy (AMN) https://ojrd.biomedcentral.com/articles/10.1186/s13023-024-03276-w Adrenomyeloneuropathy (AMN) is a progressive neurodegenerative disorder that affects adult men, leading to symptoms such as difficulty walking, bladder issues and muscle stiffness. This study evaluated the health burden and mortality rates in men with AMN in the U.S. by analysing two large healthcare databases. The study found that men with AMN […]
Adrenomyeloneuropathy (AMN) https://onlinelibrary.wiley.com/doi/10.1002/jimd.12753 Adrenomyeloneuropathy (AMN) is a common manifestation of X-linked adrenoleukodystrophy (ALD) causing progressive myeloneuropathy, which can result in imbalance and gait problems. Evaluating disease progression can be a complex process due to its variability, however, solutions do exist such as wearable sensors which offer an easy way to collect gait and balance data […]
Adrenomyeloneuropathy (AMN) https://onlinelibrary.wiley.com/doi/10.1002/ana.26849 This research article investigates X-linked adrenoleukodystrophy (X-ALD), a neurological disorder caused by mutations in the ABCD1 gene. The gene encodes a transporter responsible for degrading certain fatty acids, and the most common X-ALD phenotype adrenomyeloneuropathy (AMN), which affects the spinal cord. While previous studies mainly focused on glial cells due to the […]